NYSE:QGEN - QIAGEN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $54.33
  • Forecasted Upside: 0.00 %
  • Number of Analysts: 18
  • Breakdown:
  • 1 Sell Ratings
  • 8 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$54.33
▲ +0.6 (1.12%)
1 month | 3 months | 12 months
Get New QIAGEN Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for QGEN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for QGEN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$54.33
▲ +0.00% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for QIAGEN in the last 3 months. The average price target is $54.33, with a high forecast of $66.00 and a low forecast of $36.00. The average price target represents a 0.00% upside from the last price of $54.33.
Hold
The current consensus among 18 polled investment analysts is to hold stock in QIAGEN. This rating has held steady since April 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/3/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings
11/1/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 6 hold ratings
  • 1 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 8 hold ratings
  • 1 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 9 hold ratings
  • 1 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 8 hold ratings
  • 1 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 1 sell ratings
12/25/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 1 sell ratings
1/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/6/2021Norddeutsche LandesbankReiterated RatingHoldN/A
i
1/6/2021Nord/LBReiterated RatingNeutralN/A
i
12/14/2020DZ BankReiterated RatingSellLow
i
12/10/2020Exane BNP ParibasReiterated RatingOutperformHigh
i
12/9/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyMedium
i
12/9/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
i
11/26/2020Kepler Capital MarketsUpgradeBuyLow
i
11/11/2020DZ BankReiterated RatingSellMedium
i
11/4/2020Berenberg BankReiterated RatingBuyLow
i
10/28/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
i
10/6/2020Bank of AmericaUpgradeNeutral ➝ Buy$59.00Medium
i
9/28/2020Kepler Capital MarketsUpgradeHold ➝ Buy$59.32Medium
i
9/15/2020DZ BankReiterated RatingNeutralLow
i
8/30/2020Kepler Capital MarketsUpgradeHoldLow
i
8/26/2020Commerzbank AG (CBK.F)UpgradeHold ➝ Buy$66.00Low
i
8/24/2020CitigroupUpgradeNeutral ➝ Buy$48.00 ➝ $62.00Medium
i
8/20/2020JPMorgan Chase & Co.Reiterated RatingOverweight$60.00Low
i
8/17/2020Wolfe ResearchInitiated CoverageMarket Perform$59.00Low
i
8/17/2020Berenberg BankUpgradeHold ➝ BuyHigh
i
8/14/2020Exane BNP ParibasUpgradeNeutral ➝ OutperformHigh
i
8/14/2020BNP ParibasUpgradeNeutral ➝ OutperformMedium
i
8/14/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$32.00 ➝ $60.00High
i
7/20/2020DZ BankReiterated RatingNeutralLow
i
7/14/2020DZ BankReiterated RatingNeutralMedium
i
6/23/2020Warburg ResearchReiterated RatingHold ➝ NeutralLow
i
5/29/2020DZ BankReiterated RatingNeutralLow
i
5/6/2020Warburg ResearchReiterated RatingHoldLow
i
4/2/2020Stifel NicolausBoost Price TargetHold$33.00 ➝ $40.00Low
i
3/25/2020Kepler Capital MarketsReiterated RatingHoldLow
i
3/6/2020CfraBoost Price TargetHold$38.00 ➝ $42.00Low
i
3/4/2020Berenberg BankDowngradeBuy ➝ HoldMedium
i
3/3/2020DZ BankReiterated RatingNeutralLow
i
2/11/2020DZ BankReiterated RatingNeutralLow
i
2/6/2020CfraLower Price TargetHold$40.00 ➝ $38.00Medium
i
2/6/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
i
2/5/2020Piper SandlerBoost Price TargetNeutral$29.00 ➝ $36.00Medium
i
2/5/2020BarclaysReiterated RatingNeutralHigh
i
Rating by Jack Meehan at Barclays PLC
2/5/2020Commerzbank AG (CBK.F)Reiterated RatingNeutralMedium
i
Rating by Daniel Wendorff at Commerzbank AG (CBK.F)
1/10/2020UBS GroupLower Price TargetNeutral$39.00 ➝ $36.00Medium
i
Rating by Daniel Brennan at UBS Group AG
1/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$36.00Medium
i
1/6/2020CitigroupInitiated CoverageNeutral$35.00Low
i
1/6/2020JPMorgan Chase & Co.Reiterated RatingBuyLow
i
1/6/2020Commerzbank AG (CBK.F)DowngradeBuy ➝ HoldLow
i
Rating by Daniel Wendorff at Commerzbank AG (CBK.F)
1/2/2020DZ BankReiterated RatingNeutralLow
i
12/27/2019DZ BankReiterated RatingNeutralLow
i
12/26/2019UBS GroupReiterated RatingHold$39.00Medium
i
Rating by Daniel Brennan at UBS Group AG
12/26/2019Bank of AmericaReiterated RatingUnderperform$28.00High
i
Rating by Derik De Bruin at Bank of America Co.
11/27/2019Commerzbank AG (CBK.F)UpgradeHold ➝ BuyLow
i
Rating by Daniel Wendorff at Commerzbank AG (CBK.F)
11/22/2019DZ BankReiterated RatingBuyLow
i
11/18/2019Commerzbank AG (CBK.F)UpgradeHold ➝ Buy$48.00Medium
i
11/14/2019Stifel NicolausInitiated CoverageHold$33.00High
i
11/14/2019DZ BankReiterated RatingBuyLow
i
11/14/2019Evercore ISIUpgradeIn-Line ➝ OutperformLow
i
11/14/2019Kepler Capital MarketsUpgradeReduce ➝ HoldHigh
i
11/14/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Overweight$25.00 ➝ $40.00High
i
10/17/2019Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
i
10/9/2019UBS GroupReiterated RatingNeutralHigh
i
10/9/2019Kepler Capital MarketsDowngradeHold ➝ ReduceHigh
i
10/8/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldHigh
i
10/8/2019Bank of AmericaLower Price TargetNeutral$40.00 ➝ $33.00High
i
10/8/2019BarclaysDowngradeOverweight ➝ Equal Weight$32.00High
i
10/8/2019Piper Jaffray CompaniesLower Price TargetNeutral$36.00 ➝ $31.00High
i
10/8/2019JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$38.00 ➝ $25.00High
i
10/1/2019Berenberg BankReiterated RatingBuyHigh
i
8/1/2019The Goldman Sachs GroupReiterated RatingBuyLow
i
7/26/2019Berenberg BankReiterated RatingBuy$40.00Low
i
7/26/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
7/24/2019DZ BankReiterated RatingNeutralLow
i
7/12/2019Exane BNP ParibasUpgradeNeutral ➝ OutperformLow
i
7/12/2019BNP ParibasUpgradeNeutral ➝ OutperformLow
i
6/21/2019BarclaysBoost Price TargetOverweight$43.00 ➝ $45.00Low
i
6/21/2019The Goldman Sachs GroupReiterated RatingBuyLow
i
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
i
5/8/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
5/7/2019The Goldman Sachs GroupReiterated RatingBuyHigh
i
4/12/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyMedium
i
3/15/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$42.00Low
i
1/29/2019Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
1/21/2019Jefferies Financial GroupReiterated RatingNeutralLow
i
1/14/2019Jefferies Financial GroupReiterated RatingNeutralLow
i
10/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$39.00 ➝ $41.00Low
i
10/30/2018BarclaysReiterated RatingBuyLow
i
10/30/2018Commerzbank AG (CBK.F)Reiterated RatingBuyMedium
i
10/30/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyHigh
i
Rating by Gunnar Romer at Deutsche Bank Aktiengesellschaft
10/22/2018Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $39.00Low
i
10/5/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$43.00 ➝ $44.00Medium
i
10/5/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy ➝ Buy$43.00 ➝ $44.00Low
i
9/17/2018Commerzbank AG (CBK.F)Reiterated RatingBuyMedium
i
9/6/2018BarclaysReiterated RatingBuy$43.00Low
i
8/29/2018Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
8/7/2018Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
8/3/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyMedium
i
8/2/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$38.00 ➝ $39.00Low
i
8/2/2018CitigroupBoost Price TargetNeutral ➝ Neutral$35.00 ➝ $38.00Low
i
8/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$37.00 ➝ $38.00Low
i
7/25/2018Commerzbank AG (CBK.F)Reiterated RatingBuyMedium
i
6/6/2018Jefferies Financial GroupReiterated RatingNeutralLow
i
6/5/2018DZ BankReiterated RatingNeutralLow
i
5/16/2018The Goldman Sachs GroupReiterated RatingBuyLow
i
5/9/2018Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
5/4/2018CitigroupBoost Price TargetNeutral ➝ Neutral$31.00 ➝ $35.00Low
i
5/3/2018JPMorgan Chase & Co.Reiterated RatingNeutralLow
i
5/3/2018Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
4/24/2018Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Buy$38.00 ➝ $40.00Low
i
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$39.00 ➝ $37.00Medium
i
4/5/2018DZ BankReiterated RatingNeutralMedium
i
2/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $39.00Low
i
2/1/2018Commerzbank AG (CBK.F)Reiterated RatingBuyHigh
i
1/29/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$39.00Low
i
1/22/2018Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
1/19/2018Commerzbank AG (CBK.F)Reiterated RatingBuyMedium
i
1/10/2018Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
1/3/2018Evercore ISIInitiated CoverageOutperform$35.00Medium
i
12/21/2017CowenReiterated RatingHold$34.00Low
i
12/19/2017DZ BankReiterated RatingNeutralLow
i
12/12/2017Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
12/1/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
11/8/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
11/7/2017JPMorgan Chase & Co.Reiterated RatingNeutralN/A
i
11/7/2017Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
11/3/2017CowenReiterated RatingHold$33.00N/A
i
9/28/2017CowenReiterated RatingHold$33.00Low
i
8/28/2017DZ BankReiterated RatingNeutralLow
i
8/17/2017Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
8/14/2017CowenReiterated RatingHold$33.00Low
i
8/1/2017Independent ResearchUpgradeSell ➝ HoldLow
i
7/31/2017Jefferies Financial GroupReiterated RatingHold$25.00 ➝ $28.00Low
i
7/31/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
7/28/2017Commerzbank AG (CBK.F)Reiterated RatingBuyHigh
i
7/24/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
7/21/2017Bank of AmericaReiterated RatingNeutral$33.00 ➝ $36.00Low
i
7/17/2017BarclaysReiterated RatingOverweight$33.00 ➝ $37.00Low
i
7/13/2017Wells Fargo & CompanyReiterated RatingMarket Perform$28.00 ➝ $31.00Low
i
7/10/2017Morgan StanleyReiterated RatingOverweight$36.00 ➝ $37.00Low
i
6/23/2017Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
6/6/2017Commerzbank AG (CBK.F)Reiterated RatingBuyMedium
i
5/29/2017Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
5/29/2017DZ BankReiterated RatingNeutralLow
i
5/15/2017DZ BankReiterated RatingNeutralLow
i
5/15/2017BarclaysReiterated RatingBuy$33.00Low
i
5/15/2017Commerzbank AG (CBK.F)Reiterated RatingBuyLow
i
5/5/2017BarclaysReiterated RatingBuy$33.00Low
i
5/4/2017Evercore ISIBoost Price TargetOutperform$30.00 ➝ $31.50High
i
5/3/2017Commerzbank AG (CBK.F)Reiterated RatingBuyMedium
i
5/2/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
2/6/2017DZ BankReiterated RatingNeutralN/A
i
2/3/2017Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
2/3/2017Jefferies Financial GroupReiterated RatingNeutral ➝ HoldN/A
i
1/30/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
1/25/2017Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
1/19/2017Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
1/11/2017Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
1/9/2017BarclaysReiterated RatingBuyN/A
i
11/16/2016Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
11/3/2016JPMorgan Chase & Co.Reiterated RatingHold$27.00N/A
i
11/3/2016BarclaysReiterated RatingBuy$28.00N/A
i
11/3/2016Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
11/3/2016Bank of AmericaUpgradeUnderperform ➝ NeutralN/A
i
9/19/2016DZ BankReiterated RatingBuyN/A
i
9/16/2016Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
9/12/2016DZ BankReiterated RatingBuyN/A
i
9/11/2016Morgan StanleySet Price TargetBuy$30.00N/A
i
Rating by steve beuchaw at Morgan Stanley
9/9/2016Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
8/31/2016Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
8/4/2016Jefferies Financial GroupReiterated RatingHoldN/A
i
8/1/2016MizuhoBoost Price TargetNeutral$22.00 ➝ $25.00N/A
i
7/29/2016JPMorgan Chase & Co.Reiterated RatingHoldN/A
i
7/29/2016DZ BankReiterated RatingBuyN/A
i
7/29/2016Commerzbank AG (CBK.F)Reiterated RatingBuyN/A
i
7/25/2016Piper Jaffray CompaniesReiterated RatingNeutral$23.00N/A
i
Rating by William Quirk at Piper Jaffray Companies
6/8/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Steve Beuchaw at Morgan Stanley
6/6/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
5/26/2016Piper Jaffray CompaniesReiterated RatingHoldN/A
i
Rating by William Quirk at Piper Jaffray Companies
3/15/2016CitigroupLower Price TargetNeutral$28.00 ➝ $25.00N/A
i
2/4/2016UBS GroupLower Price Target$31.00 ➝ $29.00N/A
i
2/4/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$28.00 ➝ $27.00N/A
i
2/4/2016DZ BankReiterated RatingBuyN/A
i
2/3/2016BarclaysLower Price TargetOverweight$28.00 ➝ $27.00N/A
i
(Data available from 1/24/2016 forward)
QIAGEN logo
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc.; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. It serves molecular diagnostics, applied testing, pharma, and academia customers. The company has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and NuProbe Global. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Read More

Today's Range

Now: $54.33
$53.86
$54.69

50 Day Range

MA: $52.13
$47.84
$54.16

52 Week Range

Now: $54.33
$32.97
$55.27

Volume

536,634 shs

Average Volume

688,152 shs

Market Capitalization

$12.37 billion

P/E Ratio

67.07

Dividend Yield

N/A

Beta

0.41

Frequently Asked Questions

What sell-side analysts currently cover shares of QIAGEN?

The following Wall Street analysts have issued reports on QIAGEN in the last year: Bank of America Co., Barclays PLC, Berenberg Bank, BNP Paribas, Cfra, Citigroup Inc., Commerzbank AG (CBK.F), Deutsche Bank Aktiengesellschaft, DZ Bank AG, Exane BNP Paribas, JPMorgan Chase & Co., Kepler Capital Markets, Nord/LB, Norddeutsche Landesbank, Piper Sandler, Stifel Nicolaus, TheStreet, Warburg Research, Wolfe Research, and Zacks Investment Research.

What is the current price target for QIAGEN?

10 Wall Street analysts have set twelve-month price targets for QIAGEN in the last year. Their average twelve-month price target is $54.33, suggesting a possible upside of 0.0%. Commerzbank AG (CBK.F) has the highest price target set, predicting QGEN will reach $66.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $36.00 for QIAGEN in the next year.

What is the current consensus analyst rating for QIAGEN?

QIAGEN currently has 1 sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in QGEN, but not buy more shares or sell existing shares.

What other companies compete with QIAGEN?

How do I contact QIAGEN's investor relations team?

QIAGEN's physical mailing address is HULSTERWEG 82, VENLO P7, 5912. The company's listed phone number is 31-77-355-6600 and its investor relations email address is [email protected] The official website for QIAGEN is www.qiagen.com.